N
Natixis Portfolio holdings
AUM
$20.1B
1-Year Return
17.51%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Quarter Return
-23.62%
1 Year Return
+17.51%
3 Year Return
+106.1%
5 Year Return
+162.29%
10 Year Return
+380.38%
AUM
$27.2B
AUM Growth
-$1.46B
(-5.1%)
Cap. Flow
+$2.24B
Cap. Flow
% of AUM
8.23%
Top 10 Holdings %
Top 10 Hldgs %
54.28%
Holding
1,358
New
211
Increased
363
Reduced
403
Closed
347
Top Buys
| 1 |
Tesla
TSLA
|
+$10.1B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$375M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$323M |
| 4 |
Xcel Energy
XEL
|
+$174M |
| 5 |
DTE Energy
DTE
|
+$146M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.64B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$777M |
| 3 |
Alibaba
BABA
|
+$453M |
| 4 |
Exxon Mobil
XOM
|
+$369M |
| 5 |
Financial Select Sector SPDR Fund
XLF
|
+$232M |
Sector Composition
| 1 | Consumer Discretionary | 44.24% |
| 2 | Technology | 15.35% |
| 3 | Healthcare | 7.28% |
| 4 | Communication Services | 7.28% |
| 5 | Financials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
BorgWarner
BWA
$9.34B
| $1.28M | ﹤0.01% |
43,217
-60,047
| -58% | -$1.78M |
|
727
Kadant
KAI
$3.75B
| $1.28M | ﹤0.01% |
+7,000
| New | +$1.28M |
|
728
Abercrombie & Fitch
ANF
$4.54B
| $1.27M | ﹤0.01% |
+75,029
| New | +$1.27M |
|
729
Integra LifeSciences
IART
$1.2B
| $1.27M | ﹤0.01% |
+23,487
| New | +$1.27M |
|
730
Live Nation Entertainment
LYV
$39.6B
| $1.26M | ﹤0.01% |
15,282
-45,098
| -75% | -$3.72M |
|
731
Hess Midstream
HESM
$5.18B
| $1.26M | ﹤0.01% |
45,000
| – | – |
|
732
AGNC Investment
AGNC
$10.8B
| $1.26M | ﹤0.01% |
112,866
+64,684
| +134% | +$720K |
|
733
Belden
BDC
$5.15B
| $1.26M | ﹤0.01% |
+23,600
| New | +$1.26M |
|
734
Lantheus
LNTH
$3.57B
| $1.25M | ﹤0.01% |
+19,299
| New | +$1.25M |
|
735
Trimble
TRMB
$19.1B
| $1.25M | ﹤0.01% |
21,539
+440
| +2% | +$25.6K |
|
736
Baker Hughes
BKR
$46.3B
| $1.24M | ﹤0.01% |
42,885
-844,174
| -95% | -$24.4M |
|
737
Valmont Industries
VMI
$7.45B
| $1.22M | ﹤0.01% |
5,482
+117
| +2% | +$26K |
|
738
Schneider National
SNDR
$4.18B
| $1.22M | ﹤0.01% |
54,300
| – | – |
|
739
Interpublic Group of Companies
IPG
$9.51B
| $1.21M | ﹤0.01% |
43,916
-61,620
| -58% | -$1.7M |
|
740
ITT
ITT
$13.6B
| $1.2M | ﹤0.01% |
+17,900
| New | +$1.2M |
|
741
Tandem Diabetes Care
TNDM
$836M
| $1.2M | ﹤0.01% |
+20,219
| New | +$1.2M |
|
742
Mettler-Toledo International
MTD
$25.8B
| $1.19M | ﹤0.01% |
1,035
+284
| +38% | +$326K |
|
|
SRCL
743
DELISTED
Stericycle Inc
SRCL
| $1.19M | ﹤0.01% |
27,100
-28,600
| -51% | -$1.25M |
|
|
RVNC
744
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.18M | ﹤0.01% |
+85,000
| New | +$1.18M |
|
745
Interparfums
IPAR
$3.47B
| $1.17M | ﹤0.01% |
+16,000
| New | +$1.17M |
|
746
Innospec
IOSP
$2.06B
| $1.16M | ﹤0.01% |
+12,100
| New | +$1.16M |
|
747
Itron
ITRI
$5.41B
| $1.16M | ﹤0.01% |
23,558
-280
| -1% | -$13.8K |
|
|
DFS
748
DELISTED
Discover Financial Services
DFS
| $1.15M | ﹤0.01% |
12,206
-293,078
| -96% | -$27.7M |
|
749
Urban Edge Properties
UE
$2.64B
| $1.15M | ﹤0.01% |
+75,800
| New | +$1.15M |
|
|
SAGE
750
DELISTED
Sage Therapeutics
SAGE
| $1.14M | ﹤0.01% |
+35,200
| New | +$1.14M |
|